Blake Madden sits down with two of the people most responsible for re-wiring the employer side of healthcare right now: Dan Mendelson, CEO of Morgan Health — JPMorgan Chase’s $280M healthcare investment arm — and John Zutter, CEO of Lantern, a specialty care navigation platform now covering 12 million member lives.
The conversation covers serious ground:
- How Lantern cracked the code on surgeons of excellence at a community level
- Why Dan thinks traditional payer networks are failing
- The $10M cell & gene therapy math nobody at the employer level wants to run
- Whether AI finally makes narrow networks work this time around
- Why specialty care, oncology, infusions, and specialty drugs represent ~60% of total employer healthcare spend — and are growing 1.5x to 3x faster than overall trend
If you sell into employers, sit on a benefits committee, run a self-funded plan, or invest in this corner of the market, this one’s worth blocking off the time for.
—
Navvis partners with health systems and health plans to deliver real performance improvement across value-based care and fee-for-service models.
https://navvishealthcare.com/vbc
—
For expert analysis on healthcare M&A, strategy, finance, and markets, join 68K+ readers of Blake Madden’s Hospitalogy newsletter. Subscribe here: https://hospitalogy.com/
Like our podcast? Listen to previous episodes here: https://hospitalogy.com/podcast/
Be sure to leave us a review, and share our podcast with colleagues.
Follow Blake Madden on LinkedIn: https://www.linkedin.com/in/blakecmadden/
—
Follow Dan Mendelson on LinkedIn: https://www.linkedin.com/in/dnmendelson/
Follow John Zutter on LinkedIn: https://www.linkedin.com/in/john-zutter-687000a/